Publications by authors named "Manuel Chan"

Proteolysis-targeting chimeras (PROTACs) have been explored for the degradation of drug targets for more than two decades. However, only a handful of E3 ligase substrate receptors have been efficiently used. Downregulation and mutation of these receptors would reduce the effectiveness of such PROTACs.

View Article and Find Full Text PDF
Article Synopsis
  • - B cell lymphoma 6 (BCL6) plays a crucial role in non-Hodgkin lymphoma, especially diffuse large B-cell lymphoma (DLBCL), and its function is influenced by interactions with co-repressors.
  • - Researchers aimed to develop BCL6 inhibitors to create new treatment options for DLBCL by disrupting these co-repressor interactions, resulting in a significant virtual screening hit.
  • - The most promising candidate, OICR12694/JNJ-65234637, has shown potent inhibition of DLBCL cell growth at low concentrations and demonstrates a favorable oral pharmacokinetic profile, making it a strong candidate for further testing, especially in combination therapies.
View Article and Find Full Text PDF
Article Synopsis
  • Activating mutations in the epidermal growth factor receptor (EGFR) are prevalent in non-small cell lung cancer (NSCLC) and contribute to treatment resistance with current therapies.
  • The study introduces EMI66, a small molecule that inhibits mutant EGFR signaling through a unique mechanism, affecting receptor tyrosine kinase expression and altering the localization of COPB2 protein in lung cancer cells.
  • Results indicate that EMI66 not only impacts the ER stress response pathway but also effectively reduces the growth of mutant EGFR lung cancer cells and organoids, highlighting the potential of targeting COPB2 as a therapeutic strategy in NSCLC.
View Article and Find Full Text PDF

GMX1778 and its prodrug GMX1777 represent a new class of cancer drugs that targets nicotinamide phosphoribosyltransferase (NAMPT) as a new strategy to interfere with biosynthesis of the key enzymatic cofactor NAD, which is critical for a number of cell functions, including DNA repair. Using a genome-wide synthetic lethal siRNA screen, we identified the folate pathway-related genes, deoxyuridine triphosphatase and dihydrofolate reductase, the silencing of which sensitized non-small cell lung carcinoma (NSCLC) cells to the cytotoxic effects of GMX. Pemetrexed is an inhibitor of dihydrofolate reductase currently used to treat patients with nonsquamous NSCLC.

View Article and Find Full Text PDF

The optimization of a novel series of non-nucleoside reverse transcriptase inhibitors (NNRTI) led to the identification of pyridone 36. In cell cultures, this new NNRTI shows a superior potency profile against a range of wild type and clinically relevant, resistant mutant HIV viruses. The overall favorable preclinical pharmacokinetic profile of 36 led to the prediction of a once daily low dose regimen in human.

View Article and Find Full Text PDF

This study examined the effect of dissolved oxygen concentration on the production of biomass and metabolites with antimicrobial activity of Pseudoalteromonas sp cultured at 0, 150, 250, or 450 revolutions per minute (rev. min(-1)). Dissolved oxygen (D.

View Article and Find Full Text PDF

We describe herein a novel series of 3-amino-4-hydrazine-cyclobut-3-ene-1,2-diones as potent and selective inhibitors against the CXCR2 chemokine receptor and IL-8-mediated chemotaxis of a CXCR2-expressing cell line. Furthermore, these alkyl-hydrazine series inhibitors such as 5b demonstrated acceptable metabolic stability when incubated in human and rat microsomes.

View Article and Find Full Text PDF

Methylenetetrahydrofolate reductase (MTHFR) reduces 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the major carbon donor in the remethylation of homocysteine to methionine. Mild MTHFR deficiency, due to a common variant at nucleotide 677, has been reported to alter risk for several disorders including cardiovascular disease, neural tube defects, pregnancy complications, and certain cancers. Little is known about MTHFR regulation, since the complete cDNA and gene sequences have not been determined.

View Article and Find Full Text PDF